SFX01

Evgen Pharma has started a clinical trial of the new tablet SFX-01 | Tech Reddy

by
Evgen Pharma has started a clinical trial of the new tablet SFX-01 | Tech Reddy

[ad_1] (Alliance News) – Evgen Pharma PLC announced on Wednesday that it has started a randomized, placebo-controlled clinical trial of its new SFX-01 tablet. The Cheshire-based clinical-stage drug developer said it had dosed the first group of volunteers in the 1/1b trial after announcing on Nov. 12. It said the study aims to provide additional … Read more

Eugene to research the formulation of the new SFX-01 pill | Tech Reddy

by
Eugene to research the formulation of the new SFX-01 pill | Tech Reddy

[ad_1] The therapy allows the treatment of neurological and oncological diseases Eugen – the company developing the sulforaphane-based treatment – found that it dosed the first group of healthy volunteers in a placebo-controlled, dose-escalating phase 1/1b clinical trial of SFX-01. The therapy is a patented combination of synthetic sulforaphane and alpha-cyclodextrin. The … Read more